This publications portal is a repository of all IOM migration health publications from 2006 to present where IOM was a primary contributor.
Publications include peer-reviewed scientific papers, technical reports, training guides/manuals, policy briefs/discussion papers, factsheets, newsletters, research reviews, conference and poster presentations. These are categorized by topic, author, country/region covered as well as by year, language, and type of publication. The map reflects the countries covered by the publications.
To browse or search: simply use the filter options on the left-hand side. Alternatively, you can enter keyword/s in the search box. Selecting a specific publication will lead to a ‘download’ link or link to the website where the document is housed. Here is the step-by-step guide for your reference.
Impact of enhanced health interventions for United States–bound refugees: Evaluating best practices in migration health
Author/s: Tarissa Mitchell, Deborah Lee, Michelle Weinberg, Christina Phares, Nicola James, Kittisak Amornpaisarnloet, Lalita Aumpipat, Gretchen Cooley, Anita Davies, Valerie Daw Tin Shwe, Vasil Gajdadziev, Olga Gorbacheva, Chutharat Khwan-Niam, Alexander Klosovsky, Waritorn Madilokkowit, Diana Martin, Naing Zaw Htun Myint, Thi Ngoc Yen Nguyen, Thomas Nutman, Elise O’Connell, Luis Ortega, Sugunya Prayadsab, Chetdanai Srimanee, Wasant Supakunatom, Vattanachai Vesessmith, William Stauffer
With an unprecedented number of displaced persons worldwide, strategies for improving the health of migrating populations are critical. United States–bound refugees undergo a required overseas medical examination to identify inadmissible conditions (e.g., tuberculosis) 2–6 months before resettlement, but it is limited in scope and may miss important, preventable infectious, chronic, or nutritional causes of morbidity. We sought to evaluate the feasibility and health impact…Read more
Author/s: IOM Nepal
Tuberculosis is common in the UNHCR Bhutanese refugee camps. The IOM has identified that refugees who are not actively screened for TB through third country resettlement protocols have sputum smears with increased infectiousness. This suggests that refugees waited a prolonged period of time between the onset of symptoms and the start of treatment. This increases the risk of transmission to others due to higher levels of bacteria in the sputum and longer periods of exposure. Delay in seeking…Read more
Prevalence of bacteriologically confirmed pulmonary tuberculosis in the Bhutanese refugees in Nepal: Results of active case finding
Author/s: Olga Gorbacheva, AK Mishra, D Shapovalov, S Sudtasay
Approximately 100,000 Bhutanese refugees live in camps in southeastern Nepal. Since December 2007 the International Organization for Migration (IOM) in Nepal has conducted medical screening of Bhutanese refugees prior to resettlement in USA, Canada, Australia, New Zealand, Denmark and Norway. Screening for TB included both sputum smears and cultures. The estimated prevalence of all forms of TB was 243 per 100,000 in Nepal (WHO, 2006), and 217 per 100,000 in Bhutanese…Read more
Author/s: Anit Mishra, Olga Gorbacheva, MMT Hasan, N Rimal
Approximately 100,000 Bhutanese refugees live in seven camps in southeastern Nepal. For those offered resettlement to the USA, Canada, Australia, New Zealand, Denmark, Norway, or Netherlands, the International Organization for Migration (IOM) in Nepal conducts medical screening and arranges travel, moving up to 15,000 refugees annually. Varicella spreads primarily by airborne droplets and patients with infectious varicella are prohibited from the air travel. Varicella…Read more
Author/s: John Oeltmann, Jay Varma, Luis Ortega, Yecai Liu, Thomas O’Rourke, Maria Cano, Theresa Harrington, Sean Toney, Warren Jones, Samart Karuchit, Lois Diem, Dhanida Rienthong, Jordan Tappero, Kashef Ijaz, Susan Maloney
In January 2005, tuberculosis (TB), including multidrug-resistant TB (MDR TB), was reported among Hmong refugees who were living in or had recently immigrated to the United States from a camp in Thailand. We investigated TB and drug resistance, enhanced TB screenings, and expanded treatment capacity in the camp. In February 2005, 272 patients with TB (24 MDR TB) remained in the camp. Among 17 MDR TB patients interviewed, 13 were found to be linked socially. Of 23 MDR TB…Read more